Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors — simvastatin and pravastatin期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

Mitochondrial myopathy developing on treatment with the HMG CoA reductase inhibitors — simvastatin and pravastatin

Authors:	J. D. F. ENGLAND J. C. WALSH P. STEWART I. BOYD A. ROHAN G. M. HALMAGYI

Affiliation:	Visiting Medical Officer, Department of Cardiology, Westmead Hospital, Sydney, NSW;Staff Specialist, Department of Neurology;Staff Specialist, Department of Clinical Biochemistry, Royal Prince Alfred Hospital, Sydney, NSW;Executive Officer, Therapeutic Drugs Administration, Department of Health, Housing and Community Services, Canberra, ACT;Head, Therapeutic Drugs Administration, Department of Health, Housing and Community Services, Canberra, ACT;Staff Specialist, Department of Neurology, Royal Prince Alfred Hospital, Sydney, NSW.

Abstract:

Keywords: